﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Society of Diabetic Nephropathy Prevention</PublisherName>
      <JournalTitle>Journal of Nephropathology</JournalTitle>
      <Issn>2251-8363</Issn>
      <Volume>1</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2012</Year>
        <Month>10</Month>
        <DAY>02</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>ACE insertion/deletion (I/D) polymorphism and diabetic nephropathy</ArticleTitle>
    <FirstPage>143</FirstPage>
    <LastPage>151</LastPage>
    <ELocationID EIdType="doi">10.5812/nephropathol.8109</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Zohreh</FirstName>
        <LastName>Rahimi</LastName>
      </Author>
    </AuthorList>
    <PublicationType>REVIEW</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.5812/nephropathol.8109</ArticleId>
    </ArticleIdList>
    <History>
    </History>
    <Abstract>Context: Angiotensin converting enzyme (ACE) gene encodes ACE, a key component of renin angiotensin system (RAS), plays an important role in blood pressure homeostasis by generating the vasoconstrictor peptide angiotensin II. Evidence Acquisitions: Directory of Open Access Journals (DOAJ), Google Scholar, Pubmed (NLM), LISTA (EBSCO) and Web of Science have been searched. Results: The presence of ACE insertion/deletion (I/D) polymorphism affects the plasma level of ACE. ACE DD genotype is associated with the highest systemic and renal ACE levels compared with the lowest ACE activity in carriers of II genotype. Conclusions: In this review focus has been performed on the study of ACE I/D polymorphism in various populations and its influence on the risk of onset and progression of diabetic nephropathy. Also, association between ACE I/D polymorphism and response to ACE inhibitor and angiotensin II receptor antagonists will be reviewed. Further, synergistic effect of this polymorphism and variants of some genes on the risk of development of diabetic nephropathy will be discussed.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">ACE I/D polymorphism</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">ACE activity</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Diabetic nephropathy</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">ACE inhibitors</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Angiotensin II receptor blockers</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>